A Study to Evaluate Subcutaneously Administered rAvPAL-PEG in Patients With Phenylketonuria for 24 Weeks

Clinical trial NCT01560286 · COMPLETED

Trial details

NCT number: NCT01560286
Sponsor: BioMarin Pharmaceutical
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Phenylketonuria

Start date: 2012-05-01
Primary completion: 2013-09-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.